Prevalence of SARS-CoV-2 Antibodies in Laboratory Healthcare Workers at Assiut University Hospital, Egypt

Table 1

Effect of sociodemographic, transportation, and occupational exposure history on SARS-CoV-2 antibodies and RNA results.

Characteristics	Total N (%) (199)	Rapid test (199)					PCR (21)
		Negative (140)	Positive (59)	IgG (34)	IgM (21)	Combined (4)	Negative (10)	Positive (11)
Gender
Male	74 (37.2%)	50 (67.6%)	24 (32.4%)	14	8	2	6 (30.8%)	2 (69.2%)
Female	125 (62.8%)	90 (72%)	35 (28%)	20	13	2	4 (75.0%)	9 (25.0%)
Age groups
22–32 Ys	84 (42.2%)	60 (71.4%)	24 (28.6%)	15	9	0	2 (40.0%)	3 (60.0%)
33–43 Ys	68 (34.1%)	46 (67.6%)	22 (32.4%)	15	5	2	6 (66.7%)	3 (33.3%)
44–59 Ys	47 (23.7%)	34 (72.3%)	13 (27.7%)	4	7	2	2 (28.6%)	5 (71.4%)
Residence
Urban	128 (64.3%)	85 (66.4%)	43 (33.6%)	25	14	4	7 (50.0%)	7 (50.0%)
Rural	71 (35.7%)	55 (77.5%)	16 (22.5%)	9	7	0	3 (42.9%)	4 (57.1%)
Work area
Doctors	28 (14.1%)	20 (71.4%)	8 (28.6%)	5	3	0	2 (66.7%)	1 (33.3%)
PCR lab	13 (6.5%)	11 (84.6%)	2 (15.4%)	0	2	0	0 (0.0%)	2 (100%)
Microbiology lab	18 (9%)	12 (66.7%)	6 (33.3%)	4	1	1	1 (100%)	0
Parasitology lab	10 (5%)	9 (90%)	1 (10%)	1	0	0	—	—
Phlebotomy	9 (4.5%)	4 (44.4%)	5 (55.6%)	3	1	1	1 (100%)	0 (0.0%)
Outpatient clinic	19 (9.5%)	14 (73.7%)	5 (26.3%)	0	5	0	2 (40.0%)	3 (60.0%)
Sample receiving area	50 (25.1%)	34 (68%)	16 (32%)	11	4	1	2 (50.0%)	2 (50.0%)
Automation area	52 (26.1%)	36 (70.4%)	16 (29.6%)	10	5	1	2 (40.0%)	3 (60.0%)
Deal with COVID-19 specimen
Yes	120 (60.3%)	82 (68.3%)	38 (31.7%)	20	16	2	6 (37.5%)	10 (62.5%)
No	79 (39.7%)	58 (73.4%)	21 (26.6%)	14	5	2	4 (80.0%)	1 (20%)
Transportation
Private	61 (30.7%)	43 (70.4%)	18 (29.6%)	13	5	0	4 (80.0%)	1 (20.0%)
Public	138 (69.3%)	99 (71.7%)	39 (28.3%)	20	16	3	6 (37.5%)	10 (62.5%)
Had family COVID-19 contact
Yes	69 (34.6%)	45 (65.2%)	24 (34.8%)	13	10	1	4 (40%)	6 (60%)
No	130 (65.4%)	95 (73.1%)	35 (26.9%)	21	11	3	6 (54.5%)	5 (45.5%)

All were statistically insignificant () except significant (<0.05).